(ASHR) Xtrackers Harvest CSI 300 - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330518794

ASHR: China A-Shares, Small-Cap Stocks, Mid-Cap Stocks, Large-Cap Stocks, ETF

The Xtrackers Harvest CSI300 China A-Shares ETF (NYSE ARCA:ASHR) is an exchange-traded fund that tracks the CSI 300 Index, providing investors with exposure to the Chinese A-share market. By investing at least 80% of its assets in the securities that comprise the underlying index, the fund offers a diversified portfolio of 300 of the largest and most liquid Chinese stocks, spanning small-cap, mid-cap, and large-cap segments.

The CSI 300 Index is a widely recognized benchmark for the Chinese A-share market, reflecting the overall performance and price fluctuations of the market. As the fund is non-diversified, it is heavily reliant on the performance of the underlying index, making it essential for investors to closely monitor the indexs constituents and overall market trends.

From a technical analysis perspective, the current price of ASHR is $27.02, indicating a potential buying opportunity as it is above its 20-day and 50-day simple moving averages (SMA20: $26.81, SMA50: $26.23). However, the funds price is below its 52-week high of $35.05, suggesting a significant correction. The average true range (ATR) of 0.25, equivalent to 0.93%, indicates moderate volatility.

Considering the funds assets under management (AUM) of $2000.61M USD, it is evident that ASHR has a substantial presence in the market. Given the current technical and fundamental data, a forecast for ASHR could be that it will continue to consolidate around its current price levels, potentially breaking out above its SMA20 or SMA50 in the short term. However, a sustained rally above $28.00 could signal a stronger upward trend, while a drop below $26.00 may indicate a further decline.

To make an informed investment decision, it is crucial to closely monitor the CSI 300 Index, Chinese economic indicators, and overall market sentiment. A thorough analysis of these factors will enable investors to better understand the potential risks and opportunities associated with ASHR, ultimately making a more informed decision.

Additional Sources for ASHR ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

ASHR ETF Overview

Market Cap in USD 2,001m
Category China Region
TER 0.65%
IPO / Inception 2013-11-06

ASHR ETF Ratings

Growth Rating -14.6
Fundamental -
Dividend Rating 18.3
Rel. Strength 1
Analysts -
Fair Price Momentum 24.90 USD
Fair Price DCF -

ASHR Dividends

Dividend Yield 12m 1.13%
Yield on Cost 5y 1.13%
Annual Growth 5y -1.65%
Payout Consistency 78.1%
Payout Ratio %

ASHR Growth Ratios

Growth Correlation 3m 23.3%
Growth Correlation 12m 43.8%
Growth Correlation 5y -78.4%
CAGR 5y 0.18%
CAGR/Max DD 5y 0.00
Sharpe Ratio 12m -0.45
Alpha 5.79
Beta 0.355
Volatility 18.21%
Current Volume 5260.1k
Average Volume 20d 5181.9k
What is the price of ASHR shares?
As of June 15, 2025, the stock is trading at USD 26.75 with a total of 5,260,149 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -0.89%, over three months by -0.67% and over the past year by +12.57%.
Is Xtrackers Harvest CSI 300 a good stock to buy?
Neither. Based on ValueRay´s Analyses, Xtrackers Harvest CSI 300 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -14.64 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ASHR is around 24.90 USD . This means that ASHR is currently overvalued and has a potential downside of -6.92%.
Is ASHR a buy, sell or hold?
Xtrackers Harvest CSI 300 has no consensus analysts rating.
What are the forecasts for ASHR share price target?
According to our own proprietary Forecast Model, ASHR Xtrackers Harvest CSI 300 will be worth about 27.3 in June 2026. The stock is currently trading at 26.75. This means that the stock has a potential upside of +2.09%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 27.3 2.1%